<VariationArchive RecordType="classified" VariationID="833024" VariationName="NC_000005.10:g.(?_78089373)_(78141339_?)del" VariationType="Deletion" Accession="VCV000833024" Version="7" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-11-11" DateCreated="2020-04-15" MostRecentSubmission="2023-11-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="819607" VariationID="833024">
      <GeneList>
        <Gene Symbol="AP3B1" FullName="adaptor related protein complex 3 subunit beta 1" GeneID="8546" HGNC_ID="HGNC:566" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5q14.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="78000522" stop="78294698" display_start="78000522" display_stop="78294698" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="77298149" stop="77590527" display_start="77298149" display_stop="77590527" Strand="-" />
          </Location>
          <OMIM>603401</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000005.10:g.(?_78089373)_(78141339_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>5q14.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" innerStart="77385197" innerStop="77437163" display_start="77385197" display_stop="77437163" variantLength="51967" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.(?_77385197)_(77437163_?)del" Assembly="GRCh37">
            <Expression>NC_000005.9:g.(?_77385197)_(77437163_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000005.10:g.(?_78089373)_(78141339_?)del AND Hermansky-Pudlak syndrome 2" Accession="RCV001033486" Version="7">
        <ClassifiedConditionList TraitSetID="1768">
          <ClassifiedCondition DB="MedGen" ID="C1842362">Hermansky-Pudlak syndrome 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-03-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-03-19" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-04-15" MostRecentSubmission="2023-11-11">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16537806</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1768" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2034" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hermansky-Pudlak syndrome 2</ElementValue>
                <XRef ID="MONDO:0011997" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Platelet defects and oculocutaneous albinism</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HPS2</ElementValue>
                <XRef Type="MIM" ID="608233" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Hermansky-Pudlak syndrome (HPS) is characterized by oculocutaneous albinism, a bleeding diathesis, and, in some individuals, pulmonary fibrosis, granulomatous colitis, or immunodeficiency. Ocular findings include reduced iris pigment with iris transillumination, reduced retinal pigment, foveal hypoplasia with significant reduction in visual acuity (usually in the range of 20/50 to 20/400), nystagmus, and increased crossing of the optic nerve fibers. Hair color ranges from white to brown; skin color ranges from white to olive and is usually a shade lighter than that of other family members. The bleeding diathesis can result in variable bruising, epistaxis, gingival bleeding, postpartum hemorrhage, colonic bleeding, and prolonged bleeding with menses or after tooth extraction, circumcision, and other surgeries. Pulmonary fibrosis, a restrictive lung disease, typically causes symptoms in the early thirties and can progress to death within a decade. Granulomatous colitis is severe in about 15% of affected individuals. Neutropenia and/or immune defects occur primarily in individuals with pathogenic variants in AP3B1 and AP3D1.</Attribute>
                <XRef ID="NBK1287" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9435" />
                <XRef ID="9435" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301464</ID>
                <ID Source="BookShelf">NBK1287</ID>
              </Citation>
              <XRef ID="183678" DB="Orphanet" />
              <XRef ID="79430" DB="Orphanet" />
              <XRef ID="C1842362" DB="MedGen" />
              <XRef ID="MONDO:0011997" DB="MONDO" />
              <XRef Type="MIM" ID="608233" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2358049" SubmissionDate="2023-02-03" DateLastUpdated="2023-11-11" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="NM_003664.4_5_Deletion (exons 15-22)|MedGen:C1842362" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001196793" DateUpdated="2023-11-11" DateCreated="2020-04-15" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16537806</ID>
          </Citation>
          <Comment>This variant is a gross deletion of the genomic region encompassing exon(s) 15-22 of the AP3B1 gene. This variant would be expected to be in-frame, preserving the integrity of the reading frame. This variant has not been reported in the literature in individuals affected with AP3B1-related conditions. This variant disrupts a region of the AP3B1 protein in which other variant(s) (Deletion (Exon 15)) have been determined to be pathogenic (PMID: 16537806). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="AP3B1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000005.9:g.(?_77385197)_(77437163_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1842362" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB6933794</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2358049" TraitType="Disease" MappingType="XRef" MappingValue="C1842362" MappingRef="MedGen">
        <MedGen CUI="C1842362" Name="Hermansky-Pudlak syndrome 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

